Banco Santander’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $46.8M | Buy |
186,053
+47,263
| +34% | +$10.2M | 0.29% | 55 |
|
|
2026
Q1 | $30.2M | Sell |
138,790
-6,826
| -5% | -$1.51M | 0.24% | 67 |
|
|
2025
Q4 | $33.3M | Sell |
145,616
-7,751
| -5% | -$1.77M | 0.25% | 67 |
|
|
2025
Q3 | $35.5M | Buy |
153,367
+1,110
| +0.7% | +$226K | 0.32% | 57 |
|
|
2025
Q2 | $28.3M | Buy |
152,257
+66,231
| +77% | +$12.3M | 0.27% | 61 |
|
|
2025
Q1 | $18M | Buy |
86,026
+12,582
| +17% | +$2.45M | 0.2% | 85 |
|
|
2024
Q4 | $13.1M | Buy |
73,444
+8,907
| +14% | +$1.64M | 0.16% | 105 |
|
|
2024
Q3 | $12.7M | Sell |
64,537
-37,732
| -37% | -$7.04M | 0.15% | 108 |
|
|
2024
Q2 | $17.5M | Sell |
102,269
-70,702
| -41% | -$11.7M | 0.22% | 78 |
|
|
2024
Q1 | $31.5M | Sell |
172,971
-112,480
| -39% | -$19.4M | 0.38% | 42 |
|
|
2023
Q4 | $44.2M | Buy |
285,451
+18,531
| +7% | +$2.7M | 0.52% | 24 |
|
|
2023
Q3 | $39.8M | Buy |
266,920
+11,958
| +5% | +$1.76M | 0.56% | 20 |
|
|
2023
Q2 | $34.4M | Buy |
254,962
+81,520
| +47% | +$12M | 0.45% | 27 |
|
|
2023
Q1 | $27.6M | Sell |
173,442
-1,777
| -1% | -$272K | 0.41% | 30 |
|
|
2022
Q4 | $28.3M | Sell |
175,219
-12,094
| -6% | -$1.85M | 0.42% | 27 |
|
|
2022
Q3 | $25.1M | Sell |
187,313
-15,979
| -8% | -$2.29M | 0.34% | 34 |
|
|
2022
Q2 | $31.1M | Sell |
203,292
-4,263
| -2% | -$651K | 0.41% | 29 |
|
|
2022
Q1 | $33.6M | Sell |
207,555
-23,448
| -10% | -$3.41M | 0.36% | 35 |
|
|
2021
Q4 | $31.3M | Buy |
231,003
+11,559
| +5% | +$1.37M | 0.17% | 43 |
|
|
2021
Q3 | $23.7M | Buy |
219,444
+38,968
| +22% | +$4.45M | 0.13% | 58 |
|
|
2021
Q2 | $20.3M | Buy |
180,476
+23,860
| +15% | +$2.69M | 0.11% | 48 |
|
|
2021
Q1 | $16.9M | Buy |
156,616
+27,828
| +22% | +$2.98M | 0.12% | 61 |
|
|
2020
Q4 | $13.8M | Buy |
128,788
+11,539
| +10% | +$1.11M | 0.1% | 66 |
|
|
2020
Q3 | $10.3M | Sell |
117,249
-884
| -0.7% | -$83.2K | 0.14% | 73 |
|
|
2020
Q2 | $11.6M | Buy |
118,133
+102,689
| +665% | +$9.04M | 0.15% | 62 |
|
|
2020
Q1 | $1.18M | Buy |
15,444
+4,483
| +41% | +$382K | 0.01% | 240 |
|
|
2019
Q4 | $970K | Sell |
10,961
-6,885
| -39% | -$572K | 0.01% | 258 |
|
|
2019
Q3 | $1.35M | Buy |
17,846
+5,071
| +40% | +$348K | 0.01% | 218 |
|
|
2019
Q2 | $929K | Sell |
12,775
-902
| -7% | -$70.9K | 0.01% | 253 |
|
|
2019
Q1 | $1.1M | Sell |
13,677
-2,417
| -15% | -$198K | 0.01% | 223 |
|
|
2018
Q4 | $1.48M | Sell |
16,094
-2,163
| -12% | -$190K | 0.02% | 214 |
|
|
2018
Q3 | $1.73M | Buy |
18,257
+1,178
| +7% | +$112K | 0.02% | 208 |
|
|
2018
Q2 | $1.58M | Sell |
17,079
-254,709
| -94% | -$24.9M | 0.02% | 207 |
|
|
2018
Q1 | $25.7M | Buy |
+271,788
| New | +$29.9M | 0.3% | 53 |
|
|
2017
Q2 | – | Sell |
-3,974
| Closed | -$260K | – | 152 |
|
|
2017
Q1 | $260K | Sell |
3,974
-14,264
| -78% | -$897K | 0.01% | 125 |
|
|
2016
Q4 | $1.14M | Buy |
+18,238
| New | +$1.11M | 0.03% | 97 |
|
Other funds holding ABBV
ECSS
ATO
Banco Santander's ABBV Position: Q2 2026 in Review
Banco Santander increased its AbbVie (ABBV) stake by 34% in Q2 2026, buying an estimated $10.2M and bringing the position to 186,053 shares worth $46.8M. The position accounts for 0.29% of the portfolio, ranked #55.
Banco Santander first reported a position in ABBV in Q4 2016 and has held it in 36 quarters since. 1,793 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Banco Santander held 186,053 shares of AbbVie worth $46.8M as of Q2 2026.
- Banco Santander bought 47,263 AbbVie shares in Q2 2026, an estimated $10.2M.
- AbbVie made up 0.29% of Banco Santander's portfolio in Q2 2026, its #55 holding.
- Banco Santander first reported a position in AbbVie in Q4 2016 and has held it in 36 quarters since.
- 1,793 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Banco Santander's 13F filing for Q2 2026, filed 29 Jul 2026.